10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023

ElSayed, Nuha A., Aleppo, Grazia, Aroda, Vanita R., Bannuru, Raveendhara R., Brown, Florence M., Bruemmer, Dennis, Collins, Billy S., Das, Sandeep R. +14 more·2023·Diabetes Care
DOI 10.2337/dc23-s010

Cites (265)

Items 201–253 of 253

  1. The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics
    David Collins. Wheeler, Bergur V. Stefánsson, М. М. Батюшин, Oleksandr V. Bilchenko, David Z.I. Cherney, Glenn Matthew Chertow, Walter Douthat, Jamie P. Dwyer, Elizabeth Escudero, Roberto Pecoits‐Filho et al. · 2020 · Nephrology Dialysis Transplantation
  2. Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis
    Giugliano, Robert P., Pedersen, Terje R., Saver, Jeffrey L., Sever, Peter S., Keech, Anthony C., Bohula, Erin A., Murphy, Sabina A., Wasserman, Scott M., Honarpour, Narimon, Wang, Huei et al. · 2020 · Stroke
  3. Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials
    Bangalore, Sripal, Fakheri, Robert, Toklu, Bora, Messerli, Franz H · 2016 · BMJ
  4. Hyperkalemia after initiating renin-angiotensin system blockade: the Stockholm Creatinine Measurements (SCREAM) project
    Bandak, Ghassan, Sang, Yingying, Gasparini, Alessandro, Chang, Alex R., Ballew, Shoshana H., Evans, Marie, Arnlov, Johan, Lund, Lars H., Inker, Lesley A., Coresh, Josef et al. · 2017 · Journal of the American Heart Association
  5. Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal ( <scp>CANVAS‐R</scp> ): A randomized, placebo‐controlled trial
    Neal, Bruce, Perkovic, Vlado, Matthews, David R., Mahaffey, Kenneth W., Fulcher, Greg, Meininger, Gary, Erondu, Ngozi, Desai, Mehul, Shaw, Wayne, Vercruysse, Frank et al. · 2017 · Diabetes, Obesity and Metabolism
  6. Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort
    Andrew Paul DeFilippis, Rebekah L. Young, John William McEvoy, Erin D. Michos, Veit Sandfort, Richard A. Kronmal, Robyn L. McClelland, Michael Joseph Blaha · 2016 · European Heart Journal
  7. Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction
    Bohula, Erin A., Bonaca, Marc P., Braunwald, Eugene, Aylward, Philip E., Corbalan, Ramon, De Ferrari, Gaetano M., He, Ping, Lewis, Basil S., Merlini, Piera A., Murphy, Sabina A. et al. · 2016 · Circulation
  8. Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial
    Bhatt, Deepak L., Eikelboom, John W., Connolly, Stuart J., Steg, P. Gabriel, Anand, Sonia S., Verma, Subodh, Branch, Kelley R.H., Probstfield, Jeffrey, Bosch, Jackie, Shestakovska, Olga et al. · 2020 · Circulation
  9. Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
    Moriarty, Patrick M., Jacobson, Terry A., Bruckert, Eric, Thompson, Paul D., Guyton, John R., Baccara-Dinet, Marie T., Gipe, Daniel · 2014 · Journal of Clinical Lipidology
  10. Blood pressure targets for hypertension in people with diabetes mellitus
    Arguedas, Jose Agustin, Leiva, Viriam, Wright, James M · 2013 · Cochrane Database of Systematic Reviews
  11. Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis
    Zhang, Chunyu, Sun, Aijun, Zhang, Peng, Wu, Chaoneng, Zhang, Shuning, Fu, Mingqiang, Wang, Keqiang, Zou, Yunzeng, Ge, Junbo · 2010 · Diabetes Research and Clinical Practice
  12. Type 2 diabetes mellitus and heart failure, a scientific statement from the American Heart Association and Heart Failure Society of America
    Dunlay, Shannon M., Givertz, Michael M., Aguilar, David, Allen, Larry A., Chan, Michael, Desai, Akshay S., Deswal, Anita, Dickson, Victoria Vaughan, Kosiborod, Mikhail N., Lekavich, Carolyn L. et al. · 2019 · Journal of Cardiac Failure
  13. Sex Differences in Diabetes and Risk of Incident Coronary Artery Disease in Healthy Young and Middle-Aged Adults
    Rita Rastogi Kalyani, Mariana Lazo, Pamela Ouyang, Evrim Bengi Turkbey, Karinne Chevalier, Frederick L. Brancati, Diane M. Becker, Dhananjay M. Vaidya · 2013 · Diabetes Care
  14. Resolution of Asymptomatic Myocardial Ischemia in Patients With Type 2 Diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Study
    Wackers, Frans J. Th., Chyun, Deborah A., Young, Lawrence H., Heller, Gary V., Iskandrian, Ami E., Davey, Janice A., Barrett, Eugene J., Taillefer, Raymond, Wittlin, Steven D., Filipchuk, Neil et al. · 2007 · Diabetes Care
  15. Baseline Characteristics of Patients with Heart Failure with Preserved Ejection Fraction in the EMPEROR-Preserved Trial
    Stefan D. Anker, Javed Butler, Gerasimos S Filippatos, Muhammad Shahzeb Khan, João Pedro Ferreira, Edimar Alcides Bocchi, Michael Böhm, Hans‐Peter Brunner‐La Rocca, Dong‐Ju Choi, Vijay Chopra et al. · 2020 · European Journal of Heart Failure
  16. Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial
    Lam, Carolyn S.P., Ramasundarahettige, Chinthanie, Branch, Kelley R.H., Sattar, Naveed, Rosenstock, Julio, Pratley, Richard, Del Prato, Stefano, Lopes, Renato D., Niemoeller, Elisabeth, Khurmi, Nardev S. et al. · 2022 · Circulation
  17. Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials
    Beddhu, Srinivasan, Greene, Tom, Boucher, Robert, Cushman, William C, Wei, Guo, Stoddard, Gregory, Ix, Joachim H, Chonchol, Michel, Kramer, Holly, Cheung, Alfred K et al. · 2018 · The Lancet Diabetes &amp; Endocrinology
  18. Is "Isolated Home" Hypertension as Opposed to "Isolated Office" Hypertension a Sign of Greater Cardiovascular Risk?
    Bobrie, Guillaume, Genès, Nathalie, Vaur, Laurent, Clerson, Pierre, Vaisse, Bernard, Mallion, Jean-Michel, Chatellier, Gilles · 2001 · Archives of Internal Medicine
  19. Evening versus morning dosing regimen drug therapy for hypertension
    Ping Zhao, Ping Xu, Chaomin Wan, Zhengrong Wang · 2011 · Cochrane Database of Systematic Reviews
  20. Cardiovascular and Renal Outcomes of Renin–Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses
    Catalá-López, Ferrán, Macías Saint-Gerons, Diego, González-Bermejo, Diana, Rosano, Giuseppe M., Davis, Barry R., Ridao, Manuel, Zaragoza, Abel, Montero-Corominas, Dolores, Tobías, Aurelio, de la Fuente-Honrubia, César et al. · 2016 · PLOS Medicine
  21. Impact and efficacy of mobile health intervention in the management of diabetes and hypertension: a systematic review and meta-analysis
    Mao, Yaqian, Lin, Wei, Wen, Junping, Chen, Gang · 2020 · BMJ Open Diabetes Research &amp; Care
  22. Statins for primary prevention of cardiovascular disease
    Azeem Majeed · 2014 · BMJ
  23. Achieving Goal Blood Pressure in Patients With Type 2 Diabetes: Conventional Versus Fixed‐Dose Combination Approaches
    Bakris, George L., Weir, Matthew R., on behalf of the Study of Hypertension and the Efficacy of Lotrel in Diabetes (SHIELD) Investigators · 2003 · The Journal of Clinical Hypertension
  24. A Trial of 2 Strategies to Reduce Nocturnal Blood Pressure in Blacks With Chronic Kidney Disease
    Rahman, Mahboob, Greene, Tom, Phillips, Robert A., Agodoa, Lawrence Y., Bakris, George L., Charleston, Jeanne, Contreras, Gabriel, Gabbai, Francis, Hiremath, Leena, Jamerson, Kenneth et al. · 2013 · Hypertension
  25. Syncope, Hypotension, and Falls in the Treatment of Hypertension: Results from the Randomized Clinical Systolic Blood Pressure Intervention Trial
    Sink, Kaycee M., Evans, Gregory W., Shorr, Ronald I., Bates, Jeffrey T., Berlowitz, Dan, Conroy, Molly B., Felton, Deborah M., Gure, Tanya, Johnson, Karen C., Kitzman, Dalane et al. · 2018 · Journal of the American Geriatrics Society
  26. The relation of serum potassium concentration with cardiovascular events and mortality in community-living individuals
    Hughes-Austin, Jan M., Rifkin, Dena E., Beben, Tomasz, Katz, Ronit, Sarnak, Mark J., Deo, Rajat, Hoofnagle, Andrew N., Homma, Shunichi, Siscovick, David S., Sotoodehnia, Nona et al. · 2017 · Clinical Journal of the American Society of Nephrology
  27. Prognostic Value of Coronary Computed Tomographic Angiography in Diabetic Patients Without Known Coronary Artery Disease
    Hadamitzky, Martin, Hein, Franziska, Meyer, Tanja, Bischoff, Bernhard, Martinoff, Stefan, Schömig, Albert, Hausleiter, Jörg · 2010 · Diabetes Care
  28. Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension
    Phillips, Robert A., Xu, Jiaqiong, Peterson, Leif E., Arnold, Ryan M., Diamond, Joseph A., Schussheim, Adam E. · 2018 · Journal of the American College of Cardiology
  29. Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
    Angiolillo, Dominick J., Baber, Usman, Sartori, Samantha, Briguori, Carlo, Dangas, George, Cohen, David J., Mehta, Shamir R., Gibson, C. Michael, Chandiramani, Rishi, Huber, Kurt et al. · 2020 · Journal of the American College of Cardiology
  30. Beta Blocker Use After Acute Myocardial Infarction in the Patient with Normal Systolic Function: When is it “Ok” to Discontinue?
    Anna Kezerashvili, Kevin Phillip Marzo, Joshua De Leon · 2012 · Current Cardiology Reviews
  31. Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk
    Julio Rosenstock, Vlado Perkovic, John Hunter Alexander, Mark Emmanuel Cooper, Nikolaus Marx, Michael J. Pencina, Robert D. Toto, Christoph Wanner, Bernard Zinman, David Baanstra et al. · 2018 · Cardiovascular Diabetology
  32. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials
    Basu, Sanjay, Sussman, Jeremy B., Rigdon, Joseph, Steimle, Lauren, Denton, Brian T., Hayward, Rodney A. · 2017 · PLOS Medicine
  33. Cardiovascular Outcomes Using Doxazosin vs. Chlorthalidone for the Treatment of Hypertension in Older Adults With and Without Glucose Disorders: A Report From the ALLHAT Study
    Barzilay, Joshua I., Davis, Barry R., Bettencourt, Judy, Margolis, Karen L., Goff, David C., Black, Henry, Habib, Gabriel, Ellsworth, Allan, Force, Rex W., Wiegmann, Thomas et al. · 2004 · The Journal of Clinical Hypertension
  34. Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta‐Analysis of Randomized Controlled Trials
    Alessandro Di Minno, Roberta Lupoli, Ilenia Lorenza Calcaterra, Paolo Poggio, Francesco Forte, Gaia Spadarella, Pasquale Ambrosino, Gabriella Iannuzzo, Matteo Nicola Dario Di Minno · 2020 · Journal of the American Heart Association
  35. Metformin in Heart Failure
    Inzucchi, Silvio E., Masoudi, Frederick A., McGuire, Darren K. · 2007 · Diabetes Care
  36. Randomized controlled trial comparing impact on platelet reactivity of twice‐daily with once‐daily aspirin in people with Type 2 diabetes
    Bethel, M. A., Harrison, P., Sourij, H., Sun, Y., Tucker, L., Kennedy, I., White, S., Hill, L., Oulhaj, A., Coleman, R. L. et al. · 2016 · Diabetic Medicine
  37. The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol in Diabetes
    Ronald B Goldberg, Neil J. Stone, Scott M. Grundy · 2020 · Diabetes Care
  38. Assessment of Subclinical Coronary Atherosclerosis in Asymptomatic Patients With Type 2 Diabetes Mellitus With Single Photon Emission Computed Tomography and Coronary Computed Tomography Angiography
    Choi, Eue-Keun, Chun, Eun Ju, Choi, Sang-Il, Chang, Sung-A., Choi, Sung-Hee, Lim, Soo, Rivera, Juan J., Nasir, Khurram, Blumenthal, Roger S., Jang, Hak-Chul et al. · 2009 · The American Journal of Cardiology
  39. Individualizing Blood Pressure Targets for People With Diabetes and Hypertension: Comparing the ADA and the ACC/AHA Recommendations
    de Boer, Ian H., Bakris, George, Cannon, Christopher P. · 2018 · JAMA
  40. In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes
    Zaccardi, Francesco, Rizzi, Alessandro, Petrucci, Giovanna, Ciaffardini, Flavia, Tanese, Luigi, Pagliaccia, Francesca, Cavalca, Viviana, Ciminello, Angela, Habib, Aida, Squellerio, Isabella et al. · 2016 · Diabetes
  41. Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Trials
    Lincoff, A. Michael, Wolski, Kathy, Nicholls, Stephen J., Nissen, Steven E. · 2007 · JAMA
  42. Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study
    Meek, Claire, Wierzbicki, Anthony S., Jewkes, Christina, Twomey, Patrick J., Crook, Martin A., Jones, Alan, Viljoen, Adie · 2012 · Current Medical Research and Opinion
  43. Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease
    Sanne Bøjet Larsen, Erik Lerkevang Grove, Søs Neergaard‐Petersen, Morten Würtz, Anne‐Mette Hvas, Steen Dalby Kristensen · 2015 · PLoS ONE
  44. Evening‐ versus morning‐dosing‐regimen drug therapy for hypertension
    2011 · Prescriber
  45. The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes
    Ilkun, Olesya L., Greene, Tom, Cheung, Alfred K., Whelton, Paul K., Wei, Guo, Boucher, Robert E., Ambrosius, Walter, Chertow, Glenn M., Beddhu, Srinivasan · 2020 · Diabetes Care
  46. Antihypertensive Drug Therapy for Mild-to-Moderate Hypertension During Pregnancy
    Weihua, Liu, Qing, Guo, Xiaoyan, Yu · 2015 · Journal of Cardiovascular Nursing
  47. Efficacy and safety of bempedoic acid in patients with hypercholesterolemia: A systematic review and meta-analysis of randomized controlled trials
    Lei Dai, Yuyue Zuo, Qiqi You, Hesong Zeng, Shiyi Cao · 2020 · European Journal of Preventive Cardiology
  48. Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease
    Samia Mora, Jeffrey M. Ames, JoAnn E. Manson · 2016 · JAMA
  49. Use of diuretics during pregnancy.
    Mosa’b Al-Balas, Pina Bozzo, Adrienne Einarson · 2009 · PubMed Central
  50. Advancing Digital Health Interventions as a Clinically Applied Science for Blood Pressure Reduction: A Systematic Review and Meta-analysis
    Stogios, Nicolette, Kaur, Bhagwanpreet, Huszti, Ella, Vasanthan, Jessica, Nolan, Robert P. · 2020 · Canadian Journal of Cardiology
  51. Value of Coronary Computed Tomography Angiography in Tailoring Aspirin Therapy for Primary Prevention of Atherosclerotic Events in Patients at High Risk With Diabetes Mellitus
    Aukelien C. Dimitriu‐Leen, Arthur J.H.A. Scholte, Alexander R. van Rosendael, Inge J. van den Hoogen, A. V. Kharagjitsingh, Ron Wolterbeek, Juhani M. Knuuti, Lucia J.M. Kroft, Victoria Delgado, J. Wouter Jukema et al. · 2015 · The American Journal of Cardiology
  52. Early aspirin discontinuation after coronary stenting: a systematic review and meta-analysis
    Wiebe, Jens, Ndrepepa, Gjin, Kufner, Sebastian, Lahmann, Anna L., Xhepa, Erion, Kuna, Constantin, Voll, Felix, Gosetti, Rosanna, Laugwitz, Karl‐Ludwig, Joner, Michael et al. · 2021 · Journal of the American Heart Association
  53. Long-term Risk of Cardiovascular Events With Rosiglitazone: A Meta-analysis
    Singh, Sonal, Loke, Yoon K., Furberg, Curt D. · 2007 · JAMA